Výsledky vyhľadávania - "Hematologic malignancies"

Splicing factor mutations in hematologic malignancies Autor Chen, Sisi, Benbarche, Salima, Abdel-Wahab, Omar

“… neoplasms and several types of lymphoproliferative disorders, as well as subjects with clonal hematopoiesis…”
Zistit podrobnosti o prístupe

Chromothripsis in hematologic malignancies Autor Lagunas-Rangel, Francisco Alejandro

“…•Chromothripsis occurs in several hematologic malignancies and is associated with loss of TP53 in these malignancies…”
Získať plný text

The Impact of Reported Beta-Lactam Allergy in Hospitalized Patients with Hematologic Malignancies Requiring Antibiotics Autor Huang, Kuan-Hsiang Gary, Cluzet, Valerie, Hamilton, Keith, Fadugba, Olajumoke

“…Patients hospitalized with hematologic malignancy are particularly vulnerable to infection…”
Zistit podrobnosti o prístupe

Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) Autor Rieger, C T, Liss, B, Mellinghoff, S, Buchheidt, D, Cornely, O A, Egerer, G, Heinz, W J, Hentrich, M, Maschmeyer, G, Mayer, K, Sandherr, M, Silling, G, Ullmann, A, Vehreschild, M J G T, von Lilienfeld-Toal, M, Wolf, H H, Lehners, N

“… This guideline provides clinical recommendations on vaccine use in cancer patients including autologous stem cell transplant recipients, while allogeneic stem cell transplantation is subject of a separate guideline…”
Získať plný text

Experiences and Needs of Caregivers of Adult Patients With Hematologic Malignancies During Treatment: A Qualitative Longitudinal Study Autor Husted Nielsen, Iben, Piil, Karin, Grønbæk, Kirsten, Kjeldsen, Lars, Jarden, Mary

“… To explore the role, experiences, and needs of family caregivers of patients with hematologic malignancies during treatment…”
Zistit podrobnosti o prístupe

Serum sphingomyelin species profile is altered in hematologic malignancies Autor Hori, Atsushi, Ishida, Fumihiro, Nakazawa, Hideyuki, Yamaura, Makoto, Morita, Sunao, Uehara, Takeshi, Honda, Takayuki, Hidaka, Hiroya

“…•The SM profiles differed between four types of hematologic malignancy patients.•SM species containing saturated odd chain fatty acid from patients was lower levels compared to normal serum…”
Získať plný text

A Scoping Review of Otologic Manifestations of Hematologic Malignancies Autor Raymond, Mallory J, Ottinger, Allie, Rowley, M Andrew, Bobian, Michael, Dornhoffer, Jim, Brennan, Emily, Rizk, Habib G

“…To examine the otologic and neurotologic symptoms, physical examination findings, and imaging features secondary to hematologic malignancies…”
Zistit podrobnosti o prístupe

Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination Autor Guven, Deniz C, Sahin, Taha K, Akın, Serkan, Uckun, Fatih M

“…) to compare seroconversion rates between patients with hematologic malignancies versus healthy control subjects used the Review…”
Získať plný text

Disseminated intravascular coagulation associated with hematologic malignancies Autor Fukatsu, Masahiko

“…Hematological malignancies that are frequently complicated with disseminated intravascular coagulation (DIC) include acute leukemia, high-grade malignant…”
Zistit podrobnosti o prístupe

Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies Autor Allegra, A, Innao, V, Allegra, A.G, Pulvirenti, N, Pugliese, M, Musolino, C

“… In human immunodeficiency virus (HIV) subjects receiving PI-based treatment, an impressive decrease in the amount of HIV-associated cancers, unconnected to viral burden or CD4 amount was observed…”
Získať plný text

Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study Autor Biesdorf, Carla, Guan, Xiaowen, Siddani, Satya R., Hoffman, David, Boehm, Nils, Medeiros, Bruno C., Doi, Toshihiko, de Jonge, Maja, Rasco, Drew, Menon, Rajeev M., Polepally, Akshanth R.

“… We report the pharmacokinetics and immunogenicity of eftozanermin alfa administered intravenously to 153 adults with previously-treated solid tumors or hematologic malignancies from the first…”
Získať plný text

Function, Survival, and Care Utilization Among Older Adults With Hematologic Malignancies Autor DuMontier, Clark, Liu, Michael A., Murillo, Anays, Hshieh, Tammy, Javedan, Houman, Soiffer, Robert, Stone, Richard M., Driver, Jane A., Abel, Gregory A.

“… However, little is known regarding the role of iADLs in predicting survival and acute‐care utilization in populations of older adults with different hematologic malignancies…”
Získať plný text

Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study Autor Baumann Kreuziger, Lisa, Gaddh, Manila, Onadeko, Oluwatomiloba, George, Gemlyn, Wang, Tzu-Fei, Oo, Thein H., Jaglal, Michael, Houghton, Damon E., Streiff, Michael B., Gali, Radhika, Feng, Mingen, Simpson, Pippa, Billett, Henny H.

“…Optimal treatment of catheter-related thrombosis (CRT) is uncertain in patients with hematologic malignancy…”
Získať plný text

Prognostic significance of isochromosome 17q in hematologic malignancies Autor Koczkodaj, Dorota, Muzyka-Kasietczuk, Justyna, Chocholska, Sylwia, Podhorecka, Monika

“…Isochromosome 17q [i(17q)] with its two identical long arms is formed by duplication of the q arm and loss of the short p arm. The breakpoint in chromosome 17…”
Zistit podrobnosti o prístupe

Clinical pharmacokinetics and pharmacodynamics of ivosidenib in patients with advanced hematologic malignancies with an IDH1 mutation Autor Fan, Bin, Dai, David, DiNardo, Courtney D., Stein, Eytan, de Botton, Stéphane, Attar, Eyal C., Liu, Hua, Liu, Guowen, Lemieux, Ian, Agresta, Samuel V., Yang, Hua

“… We describe detailed pharmacokinetics and pharmacodynamics of ivosidenib in patients with advanced hematologic malignancies with an IDH1 mutation treated in a phase I study (ClinicalTrials.gov NCT02074839…”
Získať plný text

Hospital Palliative Care Team Involvement in Inpatients with Hematologic Malignancies: A Retrospective Study Autor Caspers, Anja M, Eichenauer, Dennis A, Pralong, Anne, Simon, Steffen T

“…Data on the involvement of hospital palliative care teams (HPCT) in the management of patients with hematologic malignancies (HM) are limited…”
Zistit podrobnosti o prístupe

Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: results from a phase 1 first-in-human study Autor Carla Biesdorf, Xiaowen Guan, Satya R. Siddani, David Hoffman, Nils Boehm, Bruno C. Medeiros, Toshihiko Doi, Maja de Jonge, Drew Rasco, Rajeev M. Menon, Akshanth R. Polepally

Získať plný text

FOXP1 is associated with oncogenesis and clinical outcomes in hematologic malignancies Autor Wen, Xiang-mei, Xu, Zi-jun, Ni, Hao-xi, Liu, Su-wan, Jin, Ye, Zhao, Wei, Luo, Shu-yu, Fang, Yuan-yuan, Mao, Zhen-wei, Lin, Jiang, Qian, Jun

“… However, the clinical role of FOXP1 in hematologic malignancies has not been studied comprehensively…”
Získať plný text

Population pharmacokinetic and exposure‐response analyses of ivosidenib in patients with IDH1‐mutant advanced hematologic malignancies Autor Jiang, Xuemin, Wada, Russ, Poland, Bill, Kleijn, Huub Jan, Fan, Bin, Liu, Guowen, Liu, Hua, Kapsalis, Stephanie, Yang, Hua, Le, Kha

“…‐order absorption and elimination. Between‐subject variability was moderate for PK parameters…”
Získať plný text

A Sequential Population Pharmacokinetic Model of Zilovertamab Vedotin in Patients with Hematologic Malignancies Extrapolated to the Pediatric Population Autor Zweers, Thijs J., Lommerse, Jos, van Maanen, Eline, Chatterjee, Manash S.

“…). Methods Data from a phase 1 study of zilovertamab vedotin in subjects with hematologic malignancies was used in a stepwise ADC modeling strategy based on the simplified ADC popPK model proposed by Gibiansky…”
Získať plný text